Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
International Journal of Toxicology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Becker, L. C.
Right arrow Articles by Andersen, F. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, L. C.
Right arrow Articles by Andersen, F. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Final Report of the Safety Assessment of Hyaluronic Acid, Potassium Hyaluronate, and Sodium Hyaluronate

Lillian C. Becker, MS
Wilma F. Bergfeld, MD
Donald V. Belsito, MD
Curtis D. Klaassen, PhD
James G. Marks, Jr, MD
Ronald C. Shank, PhD
Thomas J. Slaga, PhD
Paul W. Snyder, DVM, PhD
Cosmetic Ingredient Review Expert Panel
F. Alan Andersen, PhD

Technical writer, Cosmetic Ingredient Review (LCB); Member, Cosmetic Ingredient Review Expert Panel (WFB, DVB, CDK, JGM, RCS, TJS, PWS); and Director, Cosmetic Ingredient Review (FAA), Washington, DC.

Correspondence: Please address correspondence to Lillian C. Becker, MS, Cosmetic Ingredient Review, 1101 17th Street, NW, Suite 412, Washington, DC 20036; e-mail:info{at}cir-safety.org.

Hyaluronic acid, sodium hyaluronate, and potassium hyaluronate function in cosmetics as skin conditioning agents at concentrations up to 2%. Hyaluronic acid, primarily obtained from bacterial fermentation and rooster combs, does penetrate to the dermis. Hyaluronic acid was not toxic in a wide range of acute animal toxicity studies, over several species and with different exposure routes. Hyaluronic acid was not immunogenic, nor was it a sensitizer in animal studies. Hyaluronic acid was not a reproductive or developmental toxicant. Hyaluronic acid was not genotoxic. Hyaluronic acid likely does not play a causal role in cancer metastasis; rather, increased expression of hyaluronic acid genes may be a consequence of metastatic growth. Widespread clinical use of hyaluronic acid, primarily by injection, has been free of significant adverse reactions. Hyaluronic acid and its sodium and potassium salts are considered safe for use in cosmetics as described in the safety assessment.

Key Words: cosmetics • hyaluronic acid • safety

International Journal of Toxicology, Vol. 28, No. 4 Suppl, 5-67 (2009)
DOI: 10.1177/1091581809337738


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?